Executive Director, Digital Enablement

🕒 il y a 2 mois

🏄 California – Distant

🏄 California – Remote

💵 $288 000 - $335 000 / an

⏰ Temps Plein

🔴 Expert

👔 Directeur

🦅 Parrain de Visa H1B

Cette entreprise a parrainé des visas H1B par le passé.

👻 Score fantôme 1%

Ce que ça veut dire : la probabilité que cette offre reste ouverte sans recrutement actif.Comment le lire : 60 % ou plus, on pense que c'est une offre fantôme. Un score plus bas est moins inquiétant.Comment on la calcule : ancienneté, republications, postes ouverts vs taille de l'équipe, rapidité de clôture, et si le salaire est indiqué.À noter : une estimation à partir de données publiques, pas un jugement sur l'entreprise. De vraies offres peuvent avoir un score élevé, alors prenez-le comme un indice, pas comme un fait.

Postuler Maintenant

Trouver des Emplois à Distance Similaires

Configurer une alerte email pour les nouveaux emplois

📊 Vérifiez votre score de CV pour ce poste

Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

Télécharger le CV

Vaxcyte

Site WebLinkedInTous les Emplois

201 - 500 employés

Fondée en 2013

🏥 Santé

🏭 Fabrication

🧬 Biotechnologie

Healthcare • Manufacturing • Biotechnology

Vaxcyte est une entreprise innovante dans le domaine des vaccins en phase clinique, spécialisée dans l'ingénierie de vaccins haute-fidélité pour prévenir et traiter les infections bactériennes graves. L'entreprise développe des vaccins conjugués à large spectre et des vaccins protéiques innovants, en utilisant la chimie synthétique moderne et une plateforme de synthèse de protéines sans cellules, concédée sous licence par Sutro Biopharma, pour créer des antigènes protéiques difficiles à fabriquer de manière plus efficace. Ses principaux programmes comprennent des candidats vaccins conjugués antipneumococciques VAX-31 (31-valent) et VAX-24 (24-valent) en études de phase 2/3, avec des candidats en phase précoce ciblant le Streptocoque du groupe A et Shigella; Vaxcyte se concentre sur la réduction de la charge des maladies bactériennes invasives, les conséquences de la résistance aux antibiotiques et la morbidité associée dans les populations vulnérables.

Description

• The Executive Director, Digital Enablement (DE) is a newly created role with a mandate to ensure that digital and AI capabilities give Vaxcyte better leverage across every launch function • Initially focused on the commercial launch of VAX-31 for the adult indication, this role will lead the build of the digital infrastructure, AI capabilities, and commercial technology roadmap from the ground up for Vaxcyte as a first-time launching company • The Executive Director, DE serves as an enabler across functions, designing systems and capabilities so that Marketing, Sales, Medical Affairs, Market Access, Commercial Operations (e.g. 3PL, Distribution, Customer Service, etc), Data and Analytics and any other commercial teams have less friction, better intelligence, and more leverage than the competition • The DE will work collaboratively with these partners to determine business needs and recommend/build system capabilities across the organization • This role sits within the Commercial organization and works in close partnership with the IT Commercial Lead (ITCL) in the IT function, who will own implementation, data security, and technical management • This role will own strategy through execution and ensure our launch functions are fully enabled • This role also supports the digital, data, and AI needs of Medical Affairs as one of several functions it enables, while respecting the independence of Medical Affairs in setting its own scientific strategy, content, and engagement priorities • All Medical Affairs enablement operates within the company’s compliance framework, preserving the separation of promotional and non-promotional activity and the independence of scientific engagement.

🎯 Exigences

• BA/BS degree in a scientific discipline, business, marketing, or technology required • MBA or other advanced degree highly desired • Minimum of 15+ years of industry-related experience with 5+ years in commercial or commercial-facing roles within pharmaceutical, biotech, or vaccine organizations, including direct exposure to product launch • Demonstrated experience operating with a product management discipline: owned a product roadmap, managed a backlog, worked in iterative delivery cycles, and measured outcomes • Experience building or leading a commercial digital or commercial excellence function, with accountability for adoption and business results, not just technical delivery • Deep understanding of the commercial technology ecosystem, including CRM (e.g., Salesforce, Veeva, etc.), marketing automation platforms, data and analytics platforms, HCP-facing digital channels • Deep understanding of frontier AI models and their applications in business • Proven ability to translate in both directions: commercial strategy into technical requirements, and technical constraints into business options • AI fluency: genuine working knowledge of generative AI, predictive analytics, next-best-action tools, and AI-assisted content workflows • Experience launching U.S. vaccines and/or specialty biologics (highly preferred) • Familiarity with revenue management infrastructure including chargebacks, rebates, and gross-to-net systems • Familiarity with Sunshine Act compliance, MLR review workflows, and promotional materials management • Ability to travel 20% of the time for commercial and cross-functional team engagements.

🏖️ Avantages

• The compensation package will be competitive and includes comprehensive benefits • relocation assistance